194 related articles for article (PubMed ID: 29463369)
41. Norcantharidin enhances ABT-737-induced apoptosis in hepatocellular carcinoma cells by transcriptional repression of Mcl-1.
Zhang S; Li G; Ma X; Wang Y; Liu G; Feng L; Zhao Y; Zhang G; Wu Y; Ye X; Qin B; Lu J
Cell Signal; 2012 Sep; 24(9):1803-9. PubMed ID: 22609455
[TBL] [Abstract][Full Text] [Related]
42. Enhanced delivery of sorafenib with anti-GPC3 antibody-conjugated TPGS-b-PCL/Pluronic P123 polymeric nanoparticles for targeted therapy of hepatocellular carcinoma.
Gan H; Chen L; Sui X; Wu B; Zou S; Li A; Zhang Y; Liu X; Wang D; Cai S; Liu X; Liang Y; Tang X
Mater Sci Eng C Mater Biol Appl; 2018 Oct; 91():395-403. PubMed ID: 30033270
[TBL] [Abstract][Full Text] [Related]
43. Improved antitumor activity and reduced cardiotoxicity of epirubicin using hepatocyte-targeted nanoparticles combined with tocotrienols against hepatocellular carcinoma in mice.
Nasr M; Nafee N; Saad H; Kazem A
Eur J Pharm Biopharm; 2014 Sep; 88(1):216-25. PubMed ID: 24813390
[TBL] [Abstract][Full Text] [Related]
44. Functional alginate nanoparticles for efficient intracellular release of doxorubicin and hepatoma carcinoma cell targeting therapy.
Guo H; Lai Q; Wang W; Wu Y; Zhang C; Liu Y; Yuan Z
Int J Pharm; 2013 Jul; 451(1-2):1-11. PubMed ID: 23618965
[TBL] [Abstract][Full Text] [Related]
45. Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice.
Zhao X; Chen Q; Li Y; Tang H; Liu W; Yang X
Eur J Pharm Biopharm; 2015 Jun; 93():27-36. PubMed ID: 25770771
[TBL] [Abstract][Full Text] [Related]
46. Doxorubicin-loaded glycyrrhetinic acid-modified alginate nanoparticles for liver tumor chemotherapy.
Zhang C; Wang W; Liu T; Wu Y; Guo H; Wang P; Tian Q; Wang Y; Yuan Z
Biomaterials; 2012 Mar; 33(7):2187-96. PubMed ID: 22169820
[TBL] [Abstract][Full Text] [Related]
47. Atg5 siRNA inhibits autophagy and enhances norcantharidin-induced apoptosis in hepatocellular carcinoma.
Xiong X; Wu M; Zhang H; Li J; Lu B; Guo Y; Zhou T; Guo H; Peng R; Li X; Tian Q; Wang Y
Int J Oncol; 2015 Oct; 47(4):1321-8. PubMed ID: 26240015
[TBL] [Abstract][Full Text] [Related]
48. [Effects of norcantharidin on angiogenesis of human gallbladder carcinoma and its anti-angiogenic mechanisms].
Fan YZ; Chen CQ; Zhao ZM; Sun W
Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(10):693-9. PubMed ID: 16681930
[TBL] [Abstract][Full Text] [Related]
49. Norcantharidin: a potential antiangiogenic agent for gallbladder cancers in vitro and in vivo.
Zhang JT; Fan YZ; Chen CQ; Zhao ZM; Sun W
Int J Oncol; 2012 May; 40(5):1501-14. PubMed ID: 22200632
[TBL] [Abstract][Full Text] [Related]
50. Intraperitoneal administration of thermosensitive hydrogel Co-loaded with norcantharidin nanoparticles and oxaliplatin inhibits malignant ascites of hepatocellular carcinoma.
Xiao S; Wang Y; Ma W; Zhou P; Wang B; Wu Z; Wen Q; Xiong K; Liu Y; Fu S
Drug Deliv; 2022 Dec; 29(1):2713-2722. PubMed ID: 35975331
[TBL] [Abstract][Full Text] [Related]
51. Norcantharidin Nanostructured Lipid Carrier (NCTD-NLC) Suppresses the Viability of Human Hepatocellular Carcinoma HepG2 Cells and Accelerates the Apoptosis.
Yan Z; Yang K; Tang X; Bi Y; Ding Y; Deng M; Xia D; Zhao Y; Chen T
J Immunol Res; 2022; 2022():3851604. PubMed ID: 35497873
[TBL] [Abstract][Full Text] [Related]
52. Preparation of camptothecin-loaded targeting nanoparticles and their antitumor effects on hepatocellular carcinoma cell line H22.
Yang A; Liu Z; Yan B; Zhou M; Xiong X
Drug Deliv; 2016 Jun; 23(5):1699-706. PubMed ID: 25148540
[TBL] [Abstract][Full Text] [Related]
53. Enhanced delivery of doxorubicin to the liver through self-assembled nanoparticles formed via conjugation of glycyrrhetinic acid to the hydroxyl group of hyaluronic acid.
Wang X; Gu X; Wang H; Yang J; Mao S
Carbohydr Polym; 2018 Sep; 195():170-179. PubMed ID: 29804965
[TBL] [Abstract][Full Text] [Related]
54. [Inhibitory effect of norcantharidin combined with evodiamine on the growth of human hepatic carcinoma cell line HepG2 in vitro].
Liu Y; Zahng J; You Z; Liao H
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Aug; 30(8):824-8. PubMed ID: 25108435
[TBL] [Abstract][Full Text] [Related]
55. Enhanced immunotherapy of SM5-1 in hepatocellular carcinoma by conjugating with gold nanoparticles and its in vivo bioluminescence tomographic evaluation.
Ma X; Hui H; Jin Y; Dong D; Liang X; Yang X; Tan K; Dai Z; Cheng Z; Tian J
Biomaterials; 2016 May; 87():46-56. PubMed ID: 26897539
[TBL] [Abstract][Full Text] [Related]
56. Synthesis, characterization, and in vitro evaluation of curcumin-loaded albumin nanoparticles surface-functionalized with glycyrrhetinic acid.
Li J; Chen T; Deng F; Wan J; Tang Y; Yuan P; Zhang L
Int J Nanomedicine; 2015; 10():5475-87. PubMed ID: 26346750
[TBL] [Abstract][Full Text] [Related]
57. Dual-Targeted Lactoferrin Shell-Oily Core Nanocapsules for Synergistic Targeted/Herbal Therapy of Hepatocellular Carcinoma.
Abdelmoneem MA; Elnaggar MA; Hammady RS; Kamel SM; Helmy MW; Abdulkader MA; Zaky A; Fang JY; Elkhodairy KA; Elzoghby AO
ACS Appl Mater Interfaces; 2019 Jul; 11(30):26731-26744. PubMed ID: 31268657
[TBL] [Abstract][Full Text] [Related]
58. Norcantharidin combined with diamminedichloroplatinum inhibits tumor growth and cancerometastasis of hepatic carcinoma in murine.
Zhang XP; Luo LL; Liu YQ; Liu XS; An FY; Sun SB; Xie XR; Geng GQ; Chen XJ; Li ZD
J Cancer Res Ther; 2018 Dec; 14(Supplement):S1035-S1040. PubMed ID: 30539842
[TBL] [Abstract][Full Text] [Related]
59. Biodistribution and biocompatibility of glycyrrhetinic acid and galactose-modified chitosan nanoparticles as a novel targeting vehicle for hepatocellular carcinoma.
Li M; Wang Y; Jiang S; Gao Y; Zhang W; Hu S; Cheng X; Zhang C; Sun P; Ke W; Wang G; Song Z; Zhang Y; Zheng QC
Nanomedicine (Lond); 2020 Jan; 15(2):145-161. PubMed ID: 31782335
[No Abstract] [Full Text] [Related]
60. Primary in vitro and in vivo evaluation of norcantharidin-chitosan/poly (vinyl alcohol) for cancer treatment.
Li M; Xu X; Lu F; Guo S
Drug Deliv; 2014 Jun; 21(4):293-301. PubMed ID: 24156408
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]